Sign up Now to get instant access to the informative talk Dr. Peter McCullough gave to ReOpen San Diego on November 27, 2021.
PowerPoint slides are included in this presentation as well as a special interview you won’t see anywhere else!
About Dr. Peter McCullough:
An internist and cardiologist in academic practice in Dallas, TX with a Master’s in Public Health, Dr. McCullough has published over 1000 articles and has over 600 citations in the National Library of Medicine. He is a recipient of the Simon Dack Award from the American College of Cardiology and the International Vincenza Award in Critical Care Nephrology for his scholarship and research.
He serves on the editorial boards of many specialty journals and his works have appeared in the New England Journal of Medicine, Journal of the American Medical Association, Lancet, British Medical Journal, and other top journals worldwide.
Dr. McCullough has lectured on advancements in medicine around the world and been an invited lecturer to such organizations as the United States Food and Drug Administration (FDA), National Institutes of Health (NIH), New York Academy of Sciences, and the European Medicines Agency. He has served as chair or member of data safety monitoring boards of 24 randomized clinical trials.
Dr. McCullough has been a leader in the response to the Covid-19 disaster, publishing the article, “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-COV-2 (Covid-19) Infection”, the first synthesis of sequenced multi-drug treatment of Covid-19 patients in the American Journal of Medicine and then in Reviews of Cardiovascular Medicine.
He has over 50 peer-reviewed publications on SARS-COV-2 and has commented extensively on the medical response to it on FOX, OANN, Newsmax, The Hill, America Out Loud McCullough Report. On November 19, 2020 he testified before the Texas Senate Committee on Homeland Security and Government Affairs and throughout 2021 in the Texas Senate Committee on Health and Human Services, Colorado General Assembly, New Hampshire Senate, and South Carolina Senate regarding many aspects of the pandemic response.